Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2798745 in participants with diabetic macular edema. The trial was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• GSK2798745

Snippet

Sponsor: GlaxoSmithKline | Conditions: Macular Edema | Phase 1 | Status: TERMINATED | Results posted: 2024-11-08